ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 07:54 am Purchase |
2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
ADAGE CAPITAL PARTNERS GP LLC | 4,466,420 9.150% |
2,516,420 (+129.05%) |
Filing |
| 2022-02-10 09:13 am Purchase |
2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
ADAGE CAPITAL PARTNERS GP LLC | 1,950,000 5.750% |
450,000 (+30.00%) |
Filing |
| 2021-02-12 4:06 pm Purchase |
2021-02-04 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
ADAGE CAPITAL PARTNERS GP LLC | 1,500,000 5.230% |
1,500,000 (New Position) |
Filing |